Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy.

Briand F, Grasset E, Shinohara M, Cordeiro L, Richard V, Endlich N, Endlich T, Chen L, Petitjean M, de Bel T, Sulpice T

DOI: 10.1016/j.ejps.2026.107588
Published: 2026 Sep 1
Container: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejps.2026.107588,
  title = {Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy.},
  author = {Briand F and Grasset E and Shinohara M and Cordeiro L and Richard V and Endlich N and Endlich T and Chen L and Petitjean M and de Bel T and Sulpice T},
  year = {2026},
  journal = {European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  doi = {10.1016/j.ejps.2026.107588},
  url = {https://doi.org/10.1016/j.ejps.2026.107588}
}

RIS

TY  - JOUR
TI  - Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy.
AU  - Briand F
AU  - Grasset E
AU  - Shinohara M
AU  - Cordeiro L
AU  - Richard V
AU  - Endlich N
AU  - Endlich T
AU  - Chen L
AU  - Petitjean M
AU  - de Bel T
AU  - Sulpice T
PY  - 2026
JO  - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
DO  - 10.1016/j.ejps.2026.107588
UR  - https://doi.org/10.1016/j.ejps.2026.107588
ER  -

APA

F, B., E, G., M, S., L, C., V, R., N, E., T, E., L, C., M, P., T, D. B., & T, S. (2026). Quantitative image analysis reveals the benefits of dapagliflozin on glomerulosclerosis, podocyte effacement and kidney fibrosis in the SDT fatty rat model of diabetic nephropathy.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2026.107588

Source records

pubmed · retrieved 2026-09-27T01:11:38.937Z